T815-1056 Screening compound: 5-{[3-(4-METHOXYPHENYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]METHYL}-4-METHYL-1,3-THIAZOLE

T815-1056 Screening compound: 5-{[3-(4-METHOXYPHENYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]METHYL}-4-METHYL-1,3-THIAZOLE
T815-1056 Screening compound: 5-{[3-(4-METHOXYPHENYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]METHYL}-4-METHYL-1,3-THIAZOLE alternative view

Chemical Structure Depiction of ChemDiv screening compound T815-1056
5-{[3-(4-METHOXYPHENYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]METHYL}-4-METHYL-1,3-THIAZOLE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T815-1056

Molecular Formula

C17H19N5OS (C17 H19 N5 OS)

Compound Name

5-{[3-(4-METHOXYPHENYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]METHYL}-4-METHYL-1,3-THIAZOLE

IUPAC name

5-{[3-(4-methoxyphenyl)-5H6H7H8H-[124]triazolo[43-a]pyrazin-7-yl]methyl}-4-methyl-13-thiazole

SMILES

Cc1c(CN2Cc3nnc(-c(cc4)ccc4OC)n3CC2)scn1

InChI

InChI=1S/C17H19N5OS/c1-12-15(24-11-18-12)9-21-7-8-22-16(10-21)19-20-17(22)13-3-5-14(23-2)6-4-13/h3-6,11H,7-10H2,1-2H3

InChI Key

KEZUBQDMVKPPFG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29027682

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

341.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.005

Distribution Coefficient, logD

2.004

Water Solubility, LogSw

-2.26

Polar Surface Area

46.154

Acid Dissociation Constant (pKa)

18.60

Base Dissociation Constant (pKb)

4.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

T815-1056 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Female
  • Skin
  • Immune system
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T815-1056 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T815-1056?
Check Price and Availability of T815-1056, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T815-1056 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T815-1056
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T815-1056
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T815-1056 available by request